Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Atsuko Ogiso
Observed name:
A. Ogiso
Institution:
Gifu Prefectural General Medical Center
Observed institution:
Gifu Prefectural General Medical Center
ORCID:
0000-0001-6284-4899
Observed ORCID:
0000-0001-6284-4899
OpenAlex ID:
A5029507119
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)
2023
·
Manabu Futamura
, Kazuhiro Ishihara
, et al.
·
Breast Cancer
·
13
PDF
Treatment Experience of Giant Juvenile Fibroadenomas: A Report of Two Cases
2022
·
Junichi Mase
, Atsuko Ogiso
, et al.
·
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
·
1
PDF
Abstract PS3-11-11: A comparative study of trastuzumab and pertuzumab combination subcutaneous and intravenous infusion in patients with HER2-positive breast cancer: a retrospective and prospective combined study of time efficiency, cost-effectiveness, quality of life, and socioeconomic impact
2026
·
J. Mase
, A. Ogiso
, et al.
·
Clinical Cancer Research
[The Impact of Early Preoperative BRCA Genomic Test on Surgical Decision Making and the Importance of Medical Care Team].
2025
·
Junichi Mase
, Yoshimi Niwa
, et al.
·
PubMed
A Case of an Adenoid Cystic Carcinoma of the Breast
2023
·
Emiri Sugiyama
, Wakana Chikaishi
, et al.
·
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
PDF
Show more works
View as search
Works count:
5
Citation count:
14
H-index:
1
I10-index:
1
Year
Topic
Type